One inherited particle keeps hiding on ordinary blood work.

Millions of Americans get their LDL, or "bad" cholesterol, tested. But another test may do a better job of finding who needs treatment.

Lipoprotein(a) isn't part of a standard lipid panel and is largely driven by genetics. Here's why it's important to get your ...

If you are concerned about your risk of developing cardiovascular disease, you'll usually get a specific blood test to look at your cholesterol levels to see where things stand. At least, that's how ...

A routine blood test taken by millions in the U.S. each year to measure "bad" cholesterol is not the best measure to guide treatment and prevent heart attacks and strokes, suggests a new Northwestern ...

Most people who get their cholesterol checked walk away with numbers for LDL, HDL, and triglycerides, and assume they have a full picture of their heart risk. There is another particle that a standard ...

Cholesterol is a form of fat we need. It helps make the outer membranes of our bodies' cells stable. But for decades, doctors have known that people with high total cholesterol levels are more likely ...

A study conducted by researchers at the Perelman School of Medicine at the University of Pennsylvania found that by pre-ordering lipid panels—the tests that can indicate high cholesterol and help ...

Medicare covers cholesterol testing as part of cardiovascular screening blood tests, including tests for lipid and triglyceride levels, which are covered once every 5 years. For those diagnosed with ...

Researchers at The University of Queensland have developed a test that could change our understanding of cholesterol and its potential to ferry deadly cancer messages and life-saving medicines around ...

to see where things stand. At least, that’s how it has worked in the medical world for nearly 60 years. But new research suggests that a cholesterol test may not actually be the best way to identify ...

ApoB testing outperforms LDL and non-HDL cholesterol tests in predicting cardiovascular risk First study to show that using apoB testing to guide cholesterol treatment is cost-effective Currently, ...